How Hers pitches a 30-day Wegovy trial with a split-screen video | Fluid
Esc

How Hers pitches a 30-day Wegovy trial with a split-screen video

A 32-second Hers video that started running on Meta on Oct 12, 2026. The top half shows a 3D torso render; the bottom shows fingers holding a pill against a red flower, under a caption asking what would happen if you tried Wegovy for 30 days only. The voiceover pitches month-to-month access. It links to the Wegovy consultation page.

Hers
53 creatives lead here1 / 53
Hers · Wegovy consultation

Public destination captured October 22, 2026. The reference retains the page layout and loaded imagery; shopping-extension UI is removed. Offers may change. No health answers were supplied.

Hers: full page screenshot

Get started today

Visual reference: 30 days: split-screen anatomy. A three-question prequalification page introduces treatment format, motivation and wider goals before the shared weight-loss questionnaire. Price, creator, AI-care and food-noise messages all converge here. Compare the creative with the destination and explore the other ads sharing this route.

Brand
Hers
Observed offer
Medication from $149/mo, if prescribed; membership $39 first month then $149/mo
Creative angle
Education
Page type
Consultation entry
Ad format
Video · 0:32
Listed start date
Oct 12, 2026
Captured
Oct 22, 2026
Library ID
984893147984149
Destination
forhers.com

Selected for its design and offer structure. Ad performance isn’t available in this collection.

What this ad does well

The 30-days-only framing is the smart move here: it lowers the commitment of trying a prescription treatment to one month, and the voiceover backs it with month-to-month access and no commitment until you're ready. The split screen keeps two things in view at once, the body the viewer cares about and the small pill that's the product, so the format needs no explanation. The script also uses the sooner-you-start idea as a reason to act, paired with a warning not to get locked into a long-term plan. Claims about weight loss come with on-screen trial fine print, so the source is visible even if small.

What's missing

The 3D render of a glowing midsection is a generic visual that many GLP-1 ads use, and it doesn't show a person or a moment the viewer can relate to. The ad also asks what would happen in 30 days but then cites results from much longer trials in the fine print, so the hook and the proof don't line up. If you make one like this, answer your own question honestly: show what the first 30 days look like in practice (the intake, the first delivery, the first check-in) rather than implying a 30-day result. The low-commitment offer is strong enough to carry the ad on its own.

Beat by beat

  1. 0-4s
    Split screen: a glowing 3D torso on top, fingers holding a pill against a red flower below, with the 30-days-only question.

    A curiosity question plus the product in hand makes viewers want the answer.

  2. 4-12s
    The voiceover calls it the most affordable FDA-approved semaglutide on a month-to-month basis with Hers.

    It frames the offer around price and flexibility right away.

  3. 12-22s
    Captions for no commitment, no insurance, 100% online and once a day, with trial fine print for the weight-loss claims.

    Stacked objection-killers make trying it feel low-risk.

  4. 22-32s
    It says the sooner you start, the sooner you know what's right for you, warns against long-term plans, and prompts the consultation.

    It gives a reason to act now while keeping the low-commitment promise.

The offer

The voiceover leans on month-to-month access with no long-term commitment. The copy adds medication from $149/mo if prescribed, with membership at $39 for the first month and $149/month after.

Where it sends people

People land on Hers's Wegovy consultation entry page, a focused landing page that opens the intake in the hero. The first question includes a pill answer, so a viewer who just watched a pill ad can tap it immediately. The options carousel shows a "from" monthly price per medication and the FAQ covers cost and switching, which support the month-to-month promise. What the page doesn't say near the top is the no-commitment idea itself; a line in the announcement bar about month-to-month access would match the ad's main hook.

The page it sends people to: How Hers starts its Wegovy consultation inside the page hero

Hers's Wegovy consultation page opens with the first intake question in a card over the hero, then scrolls through medication cards with "from" monthly prices, a results band, membership perks, a dosing schedule and a long FAQ. 53 ads in the Fluid library send people here, including price-led, food-noise, membership-value and creator-story ads.

How the page is built

  1. 01
    Announcement bar and header

    A single line on affordability sits above a logo-only header, so the price question gets a nod before anything else and there's no navigation to wander off into.

  2. 02
    Hero with intake card

    A full-bleed portrait with a descending line-graph overlay frames a centered card that asks whether the visitor already has a treatment in mind, answering "where do I start?" with three one-tap choices.

  3. 03
    Options carousel

    Horizontal medication cards show the product, prescription and availability tags, a "from" monthly price and a safety link, answering "what are my options and what do they cost?" with pricing and eligibility fine print below.

  4. 04
    Results band

    An outdoor photo of two women carries a headline, three check items and a frosted card with a large outcome figure, which is the page's main answer to "what could this look like for me?"

  5. 05
    Membership

    A four-photo collage (provider, app, product, smart scale) sits over five check-row perks, answering "what am I paying the membership for?"

  6. 06
    Health-marker carousel

    Dark cards pair data-visualization illustrations with short benefit claims and footnotes, covering what the page says treatment can involve beyond the scale.

  7. 07
    Dosing schedule

    A chart of example monthly dose increases and a numbered four-step accordion with dose pills explain how treatment eases in, answering "what happens month to month?"

  8. 08
    FAQ

    A long accordion covers membership, cost, options, visits, insurance, HSA, eligibility, switching and side effects, catching the practical objections that are left.

  9. 09
    Footer

    Disclaimers, an app-download card with a QR code, a pharmacy certification badge and a sister-brand card close the page with trust signals and legal detail.

The first fixes we would make

  1. The membership fee is separate from the medication price, and that detail lives in fine print under the carousel. Put the combined monthly cost (medication plus membership) right under each "from" price, so a visitor who came from a price ad sees the number they'll actually pay before they start the intake.
  2. Creator-story ads send people here, but the page has no member stories or reviews to pick up that voice; the results band shows a single outcome figure instead. Add a short strip of member stories (with the same disclaimers Hers uses elsewhere) near the results band, so someone who clicked a creator's documentary finds people like that creator on the page.

Read the full breakdown of this page

Three hooks you could test

  • Sell the outcome. “Try it for one month. If it's not right for you, you're not locked in.”
  • Make the product the whole scene. “This is the whole thing: one small pill, once a day.”
  • Call out the habit you're replacing. “Don't sign up for a year before you know if something fits you.”

What to borrow for your brand

  • Frame a first purchase as a short, defined trial (30 days, one box, one month) so the commitment feels small enough to say yes.
  • Use a split screen to show the product and the result area together, which explains the ad without voiceover.
  • Pair a reason to start now with a reassurance that people can stop, so urgency doesn't read as pressure.

Transcript

What would happen if you tried Wigobi for 30 days only? You'd get the most affordable FDA approved semiglutide on a month-to-month basis with hers. No commitment needed until you are ready. No insurance required 100% online. Clinically proven to lose weight and taken just once a day. Women are losing up to 20% of their body weight. The sooner you start, the sooner you know what's right for you, and the sooner you start seeing results, don't get locked into a long-term plan before you start. Take the online consultation to get started today.
Text on screen
  • What would happen if you
  • tried Wegovy® for 30 days only
  • You'd get the most affordable
  • FDA-approved semaglutide"
  • As of April 2026, bated on poth-y aralian is can pay pite lena Booday cupph
  • on a month-to-month
  • basis with Hers
  • Actor portrayal
  • No commitment needed
  • until you are ready
  • 100% online
  • Only it prescribed
  • Clinically proven to lose weight*
  • and taken just once a day
  • overwe
  • nicol study of Wegory oral comogluside (25mg), adults wil
  • for obesity loil on org. org. body weight alongside diet and exerciti
  • Individuat resulti mey vary, Stopping treatment may result in weight regain.
  • Clinically proven to lose weight"
  • no tweak clinicol study of wegovy oral semoglutide (25mg), odüit with
  • overweight or obesity loss.on avg. 13.6% body weight alongside diet and exercito.
  • Individual results may very, Stopping treatment may result in weight regain.
  • Women are losing up to
  • 20% of their body weight*
  • People lost an average of 14% body weight
  • at 64 weeks in a clinical trial of Wegovy®
  • with swarwdighl ercbesity lost 2201 body weight of wee
  • e4, along side diot and
  • Individod resulta may vary Stopping treatmen: moy rosult nmoigh:
  • regoin.
  • 20% of their body weighte
  • at 64 weekering clinical trial of Wegovy®
  • ino i cool clinicol study of Wegovy& oral semoglutide (25mg) 27.93 of adults
  • with overweight or obesity lost ≥20% body weight at week 64, alongside diet and
  • axorcino, Individual results may vory Stopping treatment may result in weight
  • regein.
  • The sooner you start
  • The sooner you know
  • what's right for you
  • and the sooner you

One of 125 Hers ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.